Concepedia

Inge Govaerts

IG

4

Publications

189

Citations

4

H-Index

2017

Active since

Affiliations

KU Leuven(Current)

VIB-KU Leuven Center for Cancer Biology

Universitair Ziekenhuis Leuven

Inge Govaerts is an author at KU Leuven specializing in medicine, autoimmune disease, and molecular diagnostics.

ORCID

Top concepts

Publications per year

2017–2021

4

Publications

4

Mutant JAK3 phosphoproteomic profiling predicts synergism between JAK3 inhibitors and MEK/BCL2 inhibitors for the treatment of T-cell acute lymphoblastic leukemia

Sandrine Degryse, Charles E. de Bock, Sofie Demeyer et al. · Leukemia · 2017 · 86 citations · Full text

Single-cell DNA amplicon sequencing reveals clonal heterogeneity and evolution in T-cell acute lymphoblastic leukemia

Llucia Albertí Servera, Sofie Demeyer, Inge Govaerts et al. · Blood · 2020 · 68 citations · Full text

JAK/STAT Pathway Mutations in T-ALL, Including the STAT5B N642H Mutation, are Sensitive to JAK1/JAK3 Inhibitors

Inge Govaerts, Kris Jacobs, Roel Vandepoel et al. · HemaSphere · 2019 · 19 citations · Full text

, , +27

PSEN1-selective gamma-secretase inhibition in combination with kinase or XPO-1 inhibitors effectively targets T cell acute lymphoblastic leukemia

Inge Govaerts, Cristina Prieto, Charlien Vandersmissen et al. · Journal of Hematology & Oncology · 2021 · 16 citations · Full text

Rows per page

1–4 of 4